Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$2.34 - $6.75 $254,353 - $733,711
-108,698 Reduced 92.89%
8,315 $20,000
Q1 2024

May 14, 2024

BUY
$3.92 - $7.91 $449,345 - $906,715
114,629 Added 4808.26%
117,013 $758,000
Q4 2023

Feb 13, 2024

BUY
$1.78 - $4.15 $4,239 - $9,885
2,382 Added 119100.0%
2,384 $9,000
Q3 2023

Nov 13, 2023

BUY
$2.0 - $3.82 $4 - $7
2 New
2 $0
Q3 2022

Nov 14, 2022

SELL
$4.14 - $7.42 $10,875 - $19,492
-2,627 Reduced 11.66%
19,908 $90,000
Q2 2022

Aug 15, 2022

BUY
$3.43 - $5.98 $77,295 - $134,759
22,535 New
22,535 $92,000

Others Institutions Holding HOWL

About Werewolf Therapeutics, Inc.


  • Ticker HOWL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,529,400
  • Market Cap $45.5M
  • Description
  • Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...
More about HOWL
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.